New model for kinetic studies of HDL metabolism in humans

European Journal of Clinical Investigation

Volumn 34, Issue 4, 2004, Pages 262-267

  Chetiveaux M ^a   Ouguerram, K ^a   Zair, Y ^a   Maugere P ^a   Falconi, I ^a   Nazih, H ^a,b   Krempf, M ^a,b  

^a HÔTEL DIEU   (France)

^b UFR Pharmacie   (France)

Author keywords

HDL; Apolipoprotein A I; FPLC; Kinetic models; Pre 1 HDL; Stable isotope

Indexed keywords

ALPHA HIGH DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; ISOTOPE; LEUCINE; PREBETA1 HIGH DENSITY LIPOPROTEIN; TRACER; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; COMPARTMENT MODEL; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INFUSION; ISOTOPE LABELING; KINETICS; LIPOGENESIS; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TIME; ULTRACENTRIFUGATION;

ADULT; APOLIPOPROTEIN A-I; CHROMATOGRAPHY, LIQUID; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; ISOTOPES; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MALE; MODELS, BIOLOGICAL;

EID: 2142807300     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01322.x     Document Type: Article

References (30)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am J Med 1977;62:707-14.
2. Assmann G, Von Eckardstein A, Funke H. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Circulation 1993;87 (Suppl. III): III-28-III-34.
3. Rye K-A, Clay MA, Barter PJ. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 1999;145:227-38.
4. Ikewaki K, Rader DJ, Schaefer EJ, Fairwell T, Zech LA, Brewer HB. Evaluation of apo A-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res 1993;34:2207-15.
5. Schaefer JR, Rader DJ, Brewer HB Jr. Investigation of lipoprotein kinetics using endogenous labeling with stable isotopes. Curr Opin Lipidol 1992;3:227-32.
6. Chetiveaux M, Nazih H, Ferchaud-Roucher V, Lambert G, Zair Y, Masson M. et al. The differential apoA-I enrichment of prebeta (1) and alphaHDL is detectable by gel filtration separation. J Lipid Res 2002;43:1986-93.
7. Frenais R, Ouguerram K, Maugeais C, Mahot P, Maugere P, Krempf M. et al. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Diabetologia 1997;40:578-83.
8. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugation separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
9. Ordovas JM, Osgood D. Preparative isolation of plasma lipoproteins using fast protein liquid chromatography. Meth Mol Biol 2000;110:105-11.
10. März W, Siekmeier R, Scharnagl H, Seiffert UB, Gross W. Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins. Clin Chem 1993;39:2276-81.
11. Van Gent T, Van Tol A. Automated gel permeation chromatography of plasma lipoproteins by preparative fast protein liquid chromatography. J Chromatogr 1990;525:433-41.
12. Innis-Whitehouse W, Li X, Brown WV, Le N-A. An efficient chromatographic system for lipoprotein fractionning using whole plasma. J Lipid Res 1998;39:679-90.
13. Le N-A, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin. Metabolism 2000;49:167-77.
14. Frenais R, Ouguerram K, Maugeais C, Marchini JS, Benlian P, Bard JM. et al. Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study. J Lipid Res 1999;40:1506-11.
15. 3] leucine in middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol 2000;20:801-6.
16. Vélez-Carrasco W, Lichtenstein AH, Barrett PHR, Sun Z, Dolnikowski GG, Welty FK. et al. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. J Lipid Res 1999;40:1695-00.
17. Fisher WR, Venkatakrishnan V, Zech LA, Hall CM, Kilgore LL, Stacpoole PW. et al. Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans. J Lipid Res 1995;36:1618-28.
18. Akaike HA New look at the statistical model identification. IEEE Trans Automat Control 1974;AC-19:710-6.
19. O'Connor PM, Zysow BR, Schoenhaus SA, Ishida ST, Kunitake ST, Naya-Vigne JM. et al. Prebeta-1 HDL in plasma of normolipidemic individuals. influences of plasma lipoproteins, age, and gender. J Lipid Res 1998;39:670-8.
20. Lichtenstein AH, Cohn JS, Hachey DL, Millar JS, Ordovas JM, Schaefer EJ. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein AI and B100 kinetics. J Lipid Res 1990;31:1693-01.
21. 3H-leucine tracer: its use in kinetic studies of plasma lipoproteins. Metabolism 1997;46:333-42.
22. Pont F, Duvillard L, Florentin E, Gambert P, Verges B. High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study. Int J Obes 2002;26:1151-8.
23. Barrans A, Collet X, Barbaras R, Jaspard B, Manent J, Vieu C. et al. Hepatic lipase induces the formation of pre-beta1 high density lipoprotein from triacylglycerol-rich HDL2. J Biol Chem 1994;269:11572-7.
24. Sviridov D, Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 2002;161:245-54.
25. Asztalos BF, Sloop CH, Woog L, Roheim PS. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I containing subpopulations. Biochim Biophys Acta 1993;1169:291-00.
26. Kunitake ST, Mendel CM, Hennessy LK. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res 1992;33:1807-16.
27. Lamarche B, Rashid S, Lewis GF. HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 1999;286:145-61.
28. Kozyraki R, Fyfe J, Kristiansen M, Gerdes C, Jacobsen C, Cui S. et al. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat Med 1999;5:656-61.
29. Moestrup SK, Kozyraki R. Cubilin, a high-density lipoprotein receptor. Curr Opin Lipidol 2000;11:133-40.
30. Braschi S, Neville TA-M, Vohl M-C, Sparks DL. Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo. J Lip Res 1999;40:522-32.